← Back to all trials
Completed
NCT06629636
Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.
Conditions: Repeated IVF Failure, Female Infertility
Sex: Female
Ages: 32 Years – 43 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Sunkaky Medical Cooperation
Location: IVF Namba Clinic, Sankaky Medical Corporation Osaka Osaka
Summary
The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.
Eligibility Criteria
Inclusion Criteria:
* Agree to participate in the study
* 28-43 years old
* Having at least one previous embryo implantation failure
* History of low Embryo quality at day3 or day5 (according to Veeck's and Gardner's Criteria)
* No major uterine or ovarian abnormalities
* BMI level 18-25kg/m2
Exclusion Criteria:
* Ovarian endometriosis with Chocolate cysts (AFS type 3 and 4)
* Patients who have taken different supplements such as coenzyme Q10, vitamin E, carnitine,niacin, nicotinamide, or other vitamin B3-related etc. within the previous month
* Any medical contraindication of oocyte retrieval or subsequent procedures
* Couples where the husband presents with severe sperm abnormalities
* Couples where the husband presents \<5 million/mL motile sperm
* Uterine structural anomalies
* Polycystic ovaries
* Premature ovarian failure
* Individuals who need regular medication to treat chronic diseases such as diabetes, hypertension, gout, hyperuricemia, etc.
* Individuals who need drug treatment for any mental illness such as epilepsy and depression.
* Individuals who suffer from infectious diseases such as hepatitis B, active tuberculosis, AIDS, etc.
* Cancer patients or receiving chemo/radiotherapy treatment within the past 3 years.
Source: ClinicalTrials.gov (NCT06629636). StuddyBuddy aggregates publicly available trial information.